A Study of LY8888AX in Participants Using a Connected Insulin Management Platform

NCT05893797 · clinicaltrials.gov ↗

NA

Phase

COMPLETED

Status

36

Enrollment

INDUSTRY

Sponsor class

Conditions

Type 1 Diabetes
Type 2 Diabetes
Type 2 Diabetes Treated With Insulin

Interventions

DRUG: Insulin Lispro
DEVICE: Tempo Smart Button
DEVICE: Dexcom G6 CGM
DEVICE: Glooko Research Mobile App (RMA)

Sponsor

Eli Lilly and Company